NASDAQ:ORPN - Bioblast Pharma Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.1708 +0.07 (+6.36 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$1.1708
Today's Range$1.14 - $1.32
52-Week Range$0.77 - $3.75
Volume139,834 shs
Average Volume26,920 shs
Market Capitalization$3.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

Analyst Ratings

Bioblast Pharma (NASDAQ:ORPN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Bioblast Pharma (NASDAQ:ORPN) Consensus Price Target History

Price Target History for Bioblast Pharma (NASDAQ:ORPN)

Bioblast Pharma (NASDAQ:ORPN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/28/2017S&P Equity ResearchBoost Price Target$2.80 ➝ $3.15LowView Rating Details
(Data available from 2/16/2017 forward)
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel